Fundación para la Investigación del Hospital Clínico de Valencia
78
9
12
49
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
3.8%
3 terminated/withdrawn out of 78 trials
94.2%
+7.7% vs industry average
21%
16 trials in Phase 3/4
4%
2 of 49 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (78)
Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure With Preserved Ejection Fraction (EMPOWER-HFpEF)
Role: lead
Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure
Role: lead
Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
Role: lead
A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
Role: lead
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Role: lead
Tissue Characterization in STEMI Using Cardiac MRI: a Multicenter Registry
Role: lead
SHort Of Pace - Heart Failure (SHOP-HF)
Role: lead
Stress CMR With Vasodilators to Predict Long-Term Mortality
Role: lead
LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)
Role: collaborator
Evaluation of Improvements in Patient-reported Quality of Life
Role: lead
Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?
Role: lead
Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure
Role: lead
Vinorelbine in Advanced BRAF-like Colon Cancer
Role: collaborator
Synergy of Exercise and Nutrition in Preventing and Treating Frailty
Role: lead
Personalised Health Recommendations to the General Population Through an Integrated AI Guided
Role: lead
Effects of a Supervised Training Program on Functional Capacity in Patients With HFpEF and Chronotropic Incompetence
Role: lead
Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMD
Role: lead
Use of Microporous Polysaccharide Hemispheres in Breast Cancer Patients Undergoing Mastectomy
Role: lead
Validation of TAD in HER-2 with More Than 2 Lymph Nodes
Role: lead
Effects of an Exercise Program in Women Over 60 yr. With HFpEF and Sarcopenia on Functional Capacity and Quality of Life
Role: lead